Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
Clinical trial NCT00422773 · COMPLETED
Trial details
- NCT number
- NCT00422773
- Sponsor
- Technische Universität Dresden
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.